BioCatch Overview
BioCatch develops Behavioral Biometrics which analyzes an online user’s physical and cognitive digital behavior to protect individuals and their assets. Its mission is to unlock the power of behavior and deliver actionable insights to create a digital world where identity, trust and ease seamlessly co-exist. Leading financial institutions around the globe use BioCatch to more effectively fight fraud, drive digital transformation and accelerate business growth. BioCatch was named a cool vendor in Cool Vendors in Security: Identity and Access Management, 2013 by the Gartner Research Group.
Cumulative Funding Raised Over Time ($)
$145.0MApr 2020
$177.0MFeb 2024
$187.0MJun 2014
$187.6MMar 2012
$218.6MMar 2018
$225.6MMay 2016
$265.6MMay 2023
$335.6MOct 2023
$336.6MSep 2013
$356.6MSep 2020
Latest News
growth-positive
Gadi Mazor, CEO of BioCatch, added at Tech TLV: "Fifteen years ago, companies were sold for $30M. Today, deals are reaching $400 million or more, and many leaders prefer to focus on long-term growth." Ran Maidan, Senior Adviser and Head of Israel at investment firm Permira, added: "We look for a large and growing market, along with a company solving a significant problem—and BioCatch does exactly that."
BioCatch, a company focused on addressing fraud-related challenges, was acquired by investment firm Permira at a valuation of $1.3 billion. The acquisition was a result of Permiras strategic search for companies in large and growing markets with innovative products. BioCatchs annual revenue grew from $32 million to $150 million, demonstrating substantial growth. The acquisition aligns with BioCatchs long-term vision of becoming a global public company. The partnership with Permira is seen as a strategic move to support BioCatchs growth and sustainability, rather than a quick exit. The article highlights the evolving landscape of Israeli high-tech companies, with a focus on building enduring businesses.
Acquired-byInvestment
growth-positive
אקזיט אחרי 13 שנה: פרמירה רוכשת שליטה בביוקאץ' לפי שווי של 1.3 מיליארד דולר
Israeli start-up BioCatch, which has developed software for identifying and preventing fraud in the banking system, is being acquired by global fund Premiera for a valuation of $1.3 billion. Premiera will primarily purchase shares from investment funds Bain and Maverick, who entered BioCatch in 2020 at a valuation of about $300 million. The deal will see Premiera hold about 60% of BioCatch for an investment of $750 million. BioCatch, which employs 320 people, has seen accelerated growth recently, with its software successfully preventing losses of about $3.5 billion.
AcquisitionInvestment
Growth-Positive
Permira acquiring control of BioCatch at $1.3 billion valuation | CTech
Israeli fraud detection startup BioCatch is being acquired by Permira Growth Opportunities II, a fund advised by global private equity firm Permira, for around $750 million for 60% of the company, giving it a valuation of $1.3 billion. BioCatch, which developed a system for fraud detection and financial crime prevention powered by behavioral biometric intelligence, finished 2023 with 49% ARR growth, surpassing the $100 million ARR milestone and attaining EBITDA profitability. The company counts more than 190 financial institutions as customers globally, including over 30 of the worlds largest 100 global banks.
AcquisitionInvestment
growth-positive
Australian investment giant Macquarie acquires $32 million-worth of BioCatch shares | CTech
BioCatch, an Israeli unicorn specializing in software development for identifying and preventing bank fraud and money laundering, recently completed its third secondary deal in less than a year. Macquarie Capital invested $32 million in the companys shares, purchased from its early investors at a value of over $1 billion. This follows similar secondary transactions last year with Sapphire Ventures and Permira Growth Opportunities. The companys value has surged due to accelerated growth, reaching a yearly revenue pace of $100 million. BioCatch has 152 clients, including 28 of the worlds top 100 banks.
InvestmentCustomers
Growth-Positive
BioCatch Shares Guidance for Consumer Protection against Romance Scams
BioCatch, a global leader in digital fraud and money laundering prevention, has shared guidance for protecting banking customers from romance scams. The companys advice comes as authorised payment fraud continues to rise globally. In a romance scam, the victim is convinced to transfer funds to an individual they believe they are romantically involved with. BioCatch data reveals that financial scam cases surged by 19% globally in 2023. The company suggests that financial institutions should scrutinize known suspicious behaviors exhibited by fraudsters, such as the sudden initiation of accounts and frequent, hurried logins.
Customers
| Sector | Cyber Security |
Funding
| Total funding | $214.62M |
| Last funding | $32M |
| Stage | Acquired |
| Rounds | 10 |
| Investors | 18 |
Team Members
3
Employees: 201-500
Web & Social Links
| Website | www.biocatch.com |
| Careers | Careers page |
Locations
Derech Menachem Begin 132, Tel Aviv-Yafo, Israel
Sydney NSW, Australia
Singapore
Av. das Naes Unidas, 14261, So Paulo - State of So Paulo, Brazil
Mexico City, CDMX, Mexico
880 3rd Ave, New York, NY, USA
Mumbai, Maharashtra, India
London, UK
Photos & Videos
3 item(s)
BioCatch Business
Business models
B2B
Product stage
Released
Employees
201-500
Sector
Cyber SecurityIdentity SecurityTarget Customer
Financial ServicesFinancial InstitutionsBanksCommunication ServicesDiversified Telecommunication ServicesCore Technology
Artificial IntelligenceMachine LearningTags (16)
financial-institutionsauthenticationiamtransactionsmobile-securityanomaly-detectionpaymentsbehavior-analyticsbiometricscyber-securityinsurance-companiesartificial-intelligencemachine-learninganti-fraudidentity-verificationunicorn-2023Geographic Markets
GlobalBioCatch Financials
$214.62M
Total funding
Undisclosed
Capital raised
$32M
Last funding
Acquired
Funding stage
10
Total rounds
18
Investors
Cumulative Funding Raised Over Time ($)
$145.0MApr 2020
$177.0MFeb 2024
$187.0MJun 2014
$187.6MMar 2012
$218.6MMar 2018
$225.6MMay 2016
$265.6MMay 2023
$335.6MOct 2023
$336.6MSep 2013
$356.6MSep 2020
Private Equity Funding
Secondary Round
Feb 2024
$32M
Macquarie Capital, OurCrowd
Secondary Round
Oct 2023
$70M
Sapphire Ventures
Secondary Round
May 2023
$40M
Permira (Lead)
C Round
Sep 2020
$20M
Barclays, LIP Ventures, National Australia Bank (NAB), Citi, HSBC Ventures
C Round
Apr 2020
$145M
Bain Capital Ventures (Lead)
,
Maverick Ventures IsraeI, OurCrowd, American Express Ventures
B Round
Mar 2018
$30.97M
OurCrowd, Kreos Capital, NexStar Partners, American Express Ventures, CreditEase, Maverick Ventures IsraeI, Joule Ventures
Undisclosed Round
May 2016
$7.05M
OurCrowd
A Round
Jun 2014
$10M
OurCrowd (Lead)
,
Blumberg Capital, Joule Ventures
Seed
Sep 2013
$1M
Joule Ventures, Decacorn Capital
Pre-Seed
Mar 2012
$600K
Joule Ventures
Public Offering / Exit
MNAEvent
May 2024
$750M
Mergers & Acquisitions
MNAEvent
Feb 2020
Undisclosed
BioCatch Lifecycle
Cumulative Funding Raised Over Time
$145.0MApr 2020
$177.0MFeb 2024
$187.0MJun 2014
$187.6MMar 2012
$218.6MMar 2018
$225.6MMay 2016
$265.6MMay 2023
$335.6MOct 2023
$336.6MSep 2013
$356.6MSep 2020
All Events
Secondary Round
Feb 2024
$32M
Macquarie Capital, OurCrowd
Secondary Round
Oct 2023
$70M
Sapphire Ventures
Secondary Round
May 2023
$40M
Permira (Lead)
C Round
Sep 2020
$20M
Barclays, LIP Ventures, National Australia Bank (NAB), Citi, HSBC Ventures
C Round
Apr 2020
$145M
Bain Capital Ventures (Lead)
,
Maverick Ventures IsraeI, OurCrowd, American Express Ventures
B Round
Mar 2018
$30.97M
OurCrowd, Kreos Capital, NexStar Partners, American Express Ventures, CreditEase, Maverick Ventures IsraeI, Joule Ventures
Undisclosed Round
May 2016
$7.05M
OurCrowd
A Round
Jun 2014
$10M
OurCrowd (Lead)
,
Blumberg Capital, Joule Ventures
Seed
Sep 2013
$1M
Joule Ventures, Decacorn Capital
Pre-Seed
Mar 2012
$600K
Joule Ventures
MNAEvent
May 2024
$750M
MNAEvent
Feb 2020
Undisclosed
BioCatch News
41 articles
growth-positive
Gadi Mazor, CEO of BioCatch, added at Tech TLV: "Fifteen years ago, companies were sold for $30M. Today, deals are reaching $400 million or more, and many leaders prefer to focus on long-term growth." Ran Maidan, Senior Adviser and Head of Israel at investment firm Permira, added: "We look for a large and growing market, along with a company solving a significant problem—and BioCatch does exactly that."
BioCatch, a company focused on addressing fraud-related challenges, was acquired by investment firm Permira at a valuation of $1.3 billion. The acquisition was a result of Permiras strategic search for companies in large and growing markets with innovative products. BioCatchs annual revenue grew from $32 million to $150 million, demonstrating substantial growth. The acquisition aligns with BioCatchs long-term vision of becoming a global public company. The partnership with Permira is seen as a strategic move to support BioCatchs growth and sustainability, rather than a quick exit. The article highlights the evolving landscape of Israeli high-tech companies, with a focus on building enduring businesses.
Acquired-byInvestment
growth-positive
אקזיט אחרי 13 שנה: פרמירה רוכשת שליטה בביוקאץ' לפי שווי של 1.3 מיליארד דולר
Israeli start-up BioCatch, which has developed software for identifying and preventing fraud in the banking system, is being acquired by global fund Premiera for a valuation of $1.3 billion. Premiera will primarily purchase shares from investment funds Bain and Maverick, who entered BioCatch in 2020 at a valuation of about $300 million. The deal will see Premiera hold about 60% of BioCatch for an investment of $750 million. BioCatch, which employs 320 people, has seen accelerated growth recently, with its software successfully preventing losses of about $3.5 billion.
AcquisitionInvestment
Growth-Positive
Permira acquiring control of BioCatch at $1.3 billion valuation | CTech
Israeli fraud detection startup BioCatch is being acquired by Permira Growth Opportunities II, a fund advised by global private equity firm Permira, for around $750 million for 60% of the company, giving it a valuation of $1.3 billion. BioCatch, which developed a system for fraud detection and financial crime prevention powered by behavioral biometric intelligence, finished 2023 with 49% ARR growth, surpassing the $100 million ARR milestone and attaining EBITDA profitability. The company counts more than 190 financial institutions as customers globally, including over 30 of the worlds largest 100 global banks.
AcquisitionInvestment
growth-positive
Australian investment giant Macquarie acquires $32 million-worth of BioCatch shares | CTech
BioCatch, an Israeli unicorn specializing in software development for identifying and preventing bank fraud and money laundering, recently completed its third secondary deal in less than a year. Macquarie Capital invested $32 million in the companys shares, purchased from its early investors at a value of over $1 billion. This follows similar secondary transactions last year with Sapphire Ventures and Permira Growth Opportunities. The companys value has surged due to accelerated growth, reaching a yearly revenue pace of $100 million. BioCatch has 152 clients, including 28 of the worlds top 100 banks.
InvestmentCustomers
Growth-Positive
BioCatch Shares Guidance for Consumer Protection against Romance Scams
BioCatch, a global leader in digital fraud and money laundering prevention, has shared guidance for protecting banking customers from romance scams. The companys advice comes as authorised payment fraud continues to rise globally. In a romance scam, the victim is convinced to transfer funds to an individual they believe they are romantically involved with. BioCatch data reveals that financial scam cases surged by 19% globally in 2023. The company suggests that financial institutions should scrutinize known suspicious behaviors exhibited by fraudsters, such as the sudden initiation of accounts and frequent, hurried logins.
Customers
growth-positive
BioCatch Finishes Record-Breaking 2023 with Largest Sales Quarter in Company History
BioCatch, a global leader in digital fraud and money laundering detection, reported a 49% annual ARR growth for fiscal year 2023, surpassing the $100m ARR milestone. The company closed the largest sales quarter in its history and welcomed 78 new customers. The growth was primarily driven by the rapid adoption of BioCatch Connect™, the companys flagship product portfolio. The company also released BioCatch Scout, a next-generation link analysis technology. BioCatch recorded significant revenue, operational, and customer satisfaction milestones, including expanding customer relationships, protecting over 350 million banking customers globally, and preventing more than $3.5 billion in fraud since 2016.
CustomersInvestmentExpand
growth-positive
BioCatch enters unicorn club as valuation crosses $1 billion in latest secondary deal | CTech
BioCatch, a software development company specializing in identifying and preventing bank fraud and money laundering, has secured around $70 million from Sapphire Ventures, reaching a valuation of over $1 billion. This comes after a secondary deal signed on the eve of the Hamas-Israel war. The company has seen significant growth, with a 51% revenue increase from its 152 clients, which include 28 of the worlds top 100 banks. BioCatch has also expanded its focus on identifying accounts used for money laundering and terrorist financing, a sector that currently contributes about 10% to the companys revenues.
InvestmentCustomers
growth-positive
BioCatch launches data-scanning Connect solution to prevent fraud
BioCatch has launched a new version of its anti-money laundering platform, BioCatch Connect, which uses the companys behavioural biometrics technology. The platform uses AI to analyse data from various sources, including applications, devices, networks, and more. Unlike traditional fraud detection solutions, BioCatch Connect places behavioural biometric intelligence at the heart of its AI and machine-learning models. The platform is made up of three modules that collect, sequence, and visualise telemetry, providing real-time fraud interdiction, response, and investigative guidance to fraud and AML teams.
Customers
growth-positive
BioCatch® Unveils Connect™ Portfolio to Help World's Leading Brands Deliver Safe, Secure & Seamless Digital User Experiences
BioCatch, a global leader in digital fraud and money laundering detection, has announced the launch of its next-generation Connect product portfolio. This fully integrated fraud and Anti-Money Laundering (AML) product portfolio proactively detects fraudulent activities and identifies criminal actors. The launch comes at a time when financial scams have increased by 30% in the past year. BioCatch Connect uses behavioral biometric intelligence at the core of its AI and machine-learning models to enhance the accuracy of fraud and AML detection. Early access customers have reported significant returns over legacy online fraud detection platforms.
CustomersPartners
growth-positive
Permira Growth Opportunities acquires $40 million stake in BioCatch | CTech
Permira Growth Opportunities has acquired a $40 million stake in behavioral biometrics company BioCatch. The investment will provide financial backing for acquisitions and mergers and strengthen BioCatchs presence in Europe.
Investment
growth-positive
BioCatch named a 'Company to Watch in 2023' by Liminal™
BioCatch, a global leader in fraud detection and behavioral biometric intelligence, has been recognized as a Company to Watch in 2023 by Liminal, a strategy advisory firm. The companies on the list are chosen based on their momentum, product-market fit, and the current market state. BioCatchs technology analyzes over five billion digital sessions a month in real-time, helping more than 100 of the worlds largest financial institutions protect their assets and customers from fraud and identity theft. The company has experienced sustained growth and global expansion as financial crime continues to rise significantly.
Customers
growth-positive
BCU Adopts BioCatch to Bolster Fraud Detection
BCU has announced a partnership with BioCatch to leverage behavioral biometrics for fraud detection and prevention. The partnership aims to protect BCU members from cyber threats and enhance their banking experience. BioCatchs technology analyzes users physical and cognitive behavior to distinguish between genuine users and cybercriminals. It continuously monitors online sessions and provides a risk score to identify fraudulent behavior. The partnership with BioCatch is part of BCUs commitment to protecting its members financial security. Lumin Digital, a fintech company specializing in digital banking solutions, is also involved in the partnership. BCU is a purpose-driven organization with $5 billion in assets and over 300,000 members across the US and Puerto Rico.
Customers
growth-positive
Lumin Digital Partners with BioCatch to Enhance Fraud Detection Services
Lumin Digital has announced a partnership with BioCatch, a company specializing in behavioral biometric technology for advanced fraud prevention. The partnership will give Lumins network of financial institutions access to BioCatchs solutions and innovation labs that monitor emerging fraud trends. BioCatchs technology analyzes a users physical and cognitive digital behavior to distinguish between genuine users and cybercriminals. This technology will allow Lumins clients to continuously monitor for risk during online sessions, providing a secure and seamless digital experience for customers.
Partners
growth-positive
BioCatch executive says behavioral biometrics excelling for PSD2 protections | Biometric Update
BioCatchs new director of fraud strategy discusses the companys use of behavioral biometrics to fight fraud. The companys solutions monitor user behavior to detect anomalies that indicate the risk of account takeover or scams. BioCatchs Age Analysis solution, designed to tackle fraud targeting the elderly, is being well received by major banks in the U.S. The companys mule account detection tool is also effective in spotting mule accounts. BioCatch has implemented its behavioral biometrics technology for PSD2 compliance and has seen early success in detecting fraud with minimal customer friction. The company has partnerships with Microsoft and Alkami, and is expanding its footprint globally to support banks and financial institutions in fighting fraud.
CustomersPartners
growth-positive
BioCatch promotes Eyran Blumberg to Chief Operating Officer CTech
BioCatch, a behavioral biometrics startup, has appointed Eyran Blumberg as Chief Operating Officer. This move is expected to help the company expand its global operations, grow its business arena, and recruit and manage top talent. Blumberg replaces Gadi Mazor, who has been promoted to CEO. BioCatch specializes in preventing online financial fraud through innovative behavioral biometrics technology. The companys clients include American Express, HSBC, and Barclays. Since its founding, BioCatch has raised $215 million. Blumberg has over 25 years of experience in management positions at various tech companies.
Management ChangesExpand
BioCatch Obtains U.S. Patent for Mule Account Detection Solution
growth-positive
BioCatch reaches 57 patents for its behavioral biometrics, targets mule accounts Biometric Update
BioCatch, a company specializing in behavioral biometrics for fraud detection, has been granted a U.S. registered patent, bringing its total number of patents to 57. The company has expanded its presence to five continents with over 40 customers and 175 employees. BioCatch has a database of over 200 million behavioral biometric profiles and analyzes over two billion digital sessions every month. The company recently partnered with Suncorp Bank to detect mule accounts and prevent fraud. BioCatch predicts that there will be changes in legislation and industry practices to combat mule account fraud, and anticipates the implementation of progressive technologies like behavioral biometrics.
CustomersPartners
growth-positive
Major banks invest $20m in biometrics co BioCatch
Israeli behavioral biometrics company BioCatch has raised $20 million in an investment round led by Barclays, Citi, HSBC, and National Australia Bank (NAB), bringing the total raised in its Series C financing round to $168 million. Following the funding, BioCatch has established the BioCatch Client Innovation Board, which includes the four investing banks and longtime BioCatch investor American Express Ventures. The board will collaborate to develop new ways to leverage behavior attributes and combat online fraud. BioCatchs behavioral biometrics technology is used by over 40 of the worlds largest financial institutions to protect against fraud and criminal activity. The company experienced 150% growth in annual recurring revenues in 2019.
Investment
growth-positive
BioCatch and Experian Team on Fraud Prevention for Financial Services Provider - Mobile ID World
BioCatch and Experian have partnered to help a financial services provider detect and prevent fraud, resulting in $23 million in savings. The solution combines device intelligence with BioCatchs behavioral biometrics platform and addresses the increasing threat of fraud. The unnamed financial services provider reached out to Experian due to the rising fraud losses faced by companies during the COVID-19 pandemic. The partnership allows the company to catch fraud while streamlining the authentication process for legitimate customers. BioCatch has been recognized as one of CB Insights FinTech top 250 and has highlighted the need for improved account opening procedures in light of increased remote activity and the rise in account takeover fraud and mule accounts caused by the pandemic.
PartnersCustomers
BioCatch Surpasses 150 Million Anonymous Behavioral Profiles
growth-positive
AI behavioral biometric startup BioCatch raises $145 million
Behavioral biometrics startup BioCatch has raised $145 million in a series C investment, bringing its total raised to $175 million. The companys AI-driven platform analyzes behavioral parameters to generate real-time risk scores, helping combat identity theft and cybercrime. BioCatch has over 90 million users, including customers like Zelle, American Express, and Natwest. The investment will accelerate the companys growth and expand its product offerings.
InvestmentExpand
BioCatch Expands Digital Identity Leadership Position with AimBrain Acquisition
BioCatch Adds Policy Management, Case Management and Risk-Score Insights to Its Behavioral Platform
growth-negative
Biometrics News - BioCatch Warns Against Duplicate Email Fraud
BioCatchs Frances Zelazny discusses the pernicious form of fraud where fraudsters clone invoices and send duplicate emails with altered payment destinations. The victim unknowingly sends a large payment to an unknown party. BioCatch promotes its behavioral biometrics technology as a solution to prevent such fraud. The companys platform was recently added to the ForgeRock Marketplace.
Customers
growth-positive
Israeli startup targets phone scammers with new biometric trap
Israeli startup BioCatch is helping a UK bank detect and prevent authorized push payments voice scams, a new form of online fraud. BioCatch uses behavioral biometrics to analyze patterns of mouse and keyboard movements, as well as scrolling and swiping on smartphones, to identify unusual behavior that may indicate fraudulent activity. The company has developed software that checks 500 bio-behavioral, cognitive, and physiological parameters to create unique user profiles. By detecting signs of stress, hesitation, or being guided by someone, BioCatchs software can accurately identify suspicious activity. Some banks in the UK are already using BioCatchs voice scam detection software to prevent fraud.
Customers
growth-positive
BioCatch Shares More Details About Partnership with Entersekt - FindBiometrics
BioCatch has detailed its partnership with Entersekt, aimed at improving the mobile banking experience. The partnership will see Entersekt use public key infrastructure and digital certificates to make any smartphone a trusted device, while BioCatch will create a unique profile based on user behaviour and create a risk score for every transaction. The two platforms will offer frictionless password-free authentication, with the phone able to tell when the correct user is operating it. The solution aims to reduce fraud and make mobile banking simpler and safer.
Partners
growth-positive
Entersekt, BioCatch collaborate to deliver streamlined digital banking services
Entersekt and BioCatch have announced a partnership to provide streamlined and secure digital banking and payments experiences. The focus of financial institutions is shifting from driving adoption to deepening engagement and fostering customer loyalty. Entersekts Secure Platform, built on strong authentication and security technology, will be enhanced by BioCatchs behavioural biometrics technology. The collaboration aims to generate innovative use cases, such as no-password login and enhanced remote user registration. The partnership will help banks deliver intuitive and low-friction experiences while meeting regulatory requirements. The BioCatch system will send alerts to Entersekts security platform for multi-factor authentication when anomalies are detected. The partnership was announced at KNOW 2019 in Las Vegas.
Partners
growth-positive
BioCatch Gets 39th US Patent - FindBiometrics
BioCatch has been granted its 39th patent in the US, which covers a method of assessing the level of pressure a user applies to a touchscreen or electronic system. This patent further solidifies BioCatchs IP holdings and its position as a leader in the behavioral biometrics industry. The companys IP portfolio is the most robust among its competitors, and it has 25 patent applications awaiting approval. The software-based approach used by BioCatch does not require specialized hardware, allowing it to analyze 2,000 behavioral metrics. The companys commitment to innovation and market leadership is demonstrated by its investment in patents and other intellectual property.
Investment
growth-positive
BioCatch Targets Vishers in Latest Platform Enhancement - FindBiometrics
BioCatch has enhanced its AI capabilities to detect vishing, a type of APP fraud. Vishing is a scam in which a fraudster poses as a bank representative or government official to trick the target into transferring funds. BioCatchs behavioral biometrics platform can spot the subtle signs that an end user is being directed by a fraudster and immediately alert bank authorities. This enhancement is a positive growth for the company and highlights the potential of behavioral biometrics for anti-fraud and authentication applications.
Customers
growth-negative
BioCatch pitches behavioral biometrics as second factor for PSD2 to stop fraud through third parties Biometric Update
The article discusses how third-party payment providers (TPPs) under PSD2 can be targeted by fraudulent actors, posing a vulnerability for financial institutions. The security and fraud controls in place at European banks are not designed to monitor sessions originating with TPPs, making it difficult to prevent attacks. BioCatch suggests that behavioral biometrics can be used for two-factor authentication to satisfy the Strong Customer Authentication (SCA) requirement of PSD2 without introducing friction to the user experience. By continuously monitoring users before and after login, financial institutions can identify fraud and prevent account takeover attacks. BioCatch recently deployed Redis Enterprise VPC to handle its growing customer base.
PartnersCustomers
growth-positive
BioCatch forms partnership to bring behavioral biometrics to ForgeRock platform Biometric Update
BioCatch has partnered with ForgeRock to offer its behavioral biometrics capabilities on the ForgeRock platform. This integration will help protect against new account fraud and account takeover attacks. BioCatchs technology detects stolen and synthetic identities during the onboarding process and prevents account takeovers. The partnership with ForgeRock will make it easier for customers to adopt the latest identity proofing and continuous authentication technologies. BioCatch recently raised $30 million to support its growth plans and is demonstrating its technology at the ForgeRock Identity Live Conference.
Partners
growth-positive
Israel wins second-largest number of cybersecurity deals globally
Israeli startups BioCatch, Cylus, and D-ID are among the 26 cybersecurity firms selected by CB Insights that are transforming the industry. Israel accounted for the second-largest number of cybersecurity deals globally, behind the US and ahead of the UK. The report selects 29 cybersecurity startups, with six of them being Israeli firms. The Israeli firms on the list are BioCatch, Aqua Security, IRONSCALES, D-ID, Minerva Labs, and Cylus. The report also mentions that 62% of the selected companies have their headquarters in the US, followed by Israel. The report excludes unicorns and focuses on early- to mid-stage companies. Last year, global deals and financing of cybersecurity firms reached $7.7 billion in 552 deals, with three Israeli firms mentioned in the report.
PartnersCustomers
growth-positive
BioCatch Wins "Best Innovation in Securing Transactions" at Florin Awards - Mobile ID World
BioCatch has won the Best Innovation in Securing Transactions award at the European Payments Summits Florin Awards. The award recognizes BioCatchs behavioral biometrics solution for mobile authentication. The system assesses over 2,000 metrics to establish a user profile based on behavioral patterns. BioCatch recently raised $30 million in its latest round of financing. The company is committed to increasing the adoption of behavioral biometrics market-wide.
Investment
growth-positive
BioCatch VP touts behavioral biometrics as wave of the future Biometric Update
BioCatch, a market leader in behavioral biometrics, offers a solution to reduce transaction friction, decrease fraud, and provide quantifiable business value. The companys enterprise-grade solution is used by major banks and e-commerce sites worldwide and currently monitors over four billion transactions per month. BioCatchs technology analyzes the way people interact with online applications or devices, capturing a wide array of human interactions. The company aims to address the growing threat of social engineering and account takeover, which is the fastest growing type of fraud. By analyzing user behavior in real-time, BioCatchs platform can determine the legitimacy of a user and transaction, preventing identity theft and account takeover. The company expects continued growth in behavioral biometrics as traditional fraud prevention methods have proven to be limited in effectiveness.
Customers
growth-positive
Global Cybersecurity Firm BioCatch Granted Breakthrough Patent for Detecting Remote Access, Among the Most Persistent Cyber Threats Today
BioCatch, a global leader in Behavioral Biometrics, has been awarded a new patent for detecting remote access users and differentiating between genuine and malicious online behaviors. The patent focuses on detecting remote access tools, including social engineering techniques, to gain unauthorized access to victim accounts. Traditional malware detection and device verification tools are ineffective against these attacks. BioCatchs approach of analyzing user behavior in online sessions provides a more effective way to identify next-generation threats. With this new patent, BioCatchs intellectual property portfolio now consists of 48 granted and pending patents. The company has been recognized for its innovative approach to cybersecurity and has received awards for new product innovation. BioCatch monitors over 4 billion transactions per month.
Investment
growth-positive
Biometric Authentication Provides Body of Evidence
The article discusses the rise of biometric authentication as a replacement for alphanumeric passwords. It highlights several startups and companies in the biometrics market, including EyeVerify, Nymi, Descartes Biometrics, Nuance Communications, BioCatch, TypingDNA, and HYPR. EyeVerify, backed by investments from Wells Fargo, offers EyePrint ID software for biometric authentication. The article mentions the expected growth of the biometrics market to reach $24 billion by 2020. It also mentions the increasing adoption of biometric authentication in the mobile market. The article provides brief descriptions of each companys biometric authentication technology and their potential applications. TypingDNA recently raised $7 million in Series A funding, while HYPR raised $35 million in Series C funding.
Customers
growth-positive
INTERVIEW: Frances Zelazny, Vice President of Marketing, BioCatch - FindBiometrics
The article features an interview with Frances Zelazny, Vice President of Marketing at BioCatch, a company specializing in behavioral biometrics. The interview discusses the growing popularity of behavioral biometrics as a biometric modality, driven by the need for a new approach to cybersecurity. BioCatchs IP growth and patents related to authentication are also highlighted. The advantages of behavioral biometrics in authentication and its applications in threat detection, particularly in the banking and payments sector, are discussed. The deployment process of BioCatchs technology is described as simple and easy. Overall, the article portrays a positive impact on BioCatchs growth and emphasizes the importance of behavioral biometrics in the cybersecurity landscape.
CustomersPartners
BioCatch CEO: N.Y.C. regs 'need to be more explicit' in addressing cyber threats - New York Business Journal
growth-positive
BioCatch tracks memory use to catch cybercrooks
Israeli start-up BioCatch uses behavioral biometrics to distinguish between good and criminal users. Their latest product, Criminal Behavior, helps identify impostors by analyzing behavior patterns that differ when using short-term vs long-term memory. The software alerts banks and e-commerce sites if the person performing actions isnt who they should be. BioCatchs technology has already been deployed in tier-one banks and eCommerce customers. The company has raised a total of about $12 million from investors and has over 33 million banking customers globally.
Customers
growth-positive
Pre-Crime Startup BioCatch Authenticates Users Via Touch And Your Phone's Accelerometer
Israeli startup BioCatch has been granted a patent for its behavioral biometric authentication and threat detection technology. The technology allows app developers to authenticate users based on their interaction with their phones touch screen and accelerometer. BioCatch has raised $10 million in Series A funding, led by OurCrowd and Blumberg Capital, to develop this technology. The patent covers the use of physiological factors and behavioral traits to ensure the users identity. The purpose of the technology is to provide an additional layer of security to prevent online fraud before it happens. BioCatchs technology operates in the something you are area of multi-factor authentication.
Investment
growth-positive
Pre-Crime Startup BioCatch Raises $10M Series A
Israeli startup BioCatch has closed a $10 million Series A round led by OurCrowd and Blumberg Capital. The funding will be used to expand BioCatchs R&D efforts and drive growth in key markets. BioCatch uses behavioral biometric authentication and threat detection technology to help banks and e-commerce companies prevent online fraud. It collects and analyzes over 400 bio-behavioral, cognitive, and physiological parameters to create unique user profiles and reduce risky transactions. The companys invisible challenges feature records and analyzes user behavior to authenticate them and identify behaviors consistent with fraudsters. BioCatchs technology has been deployed in eight banks, eCommerce sites, and enterprises in six countries. Prior to the Series A round, BioCatch raised $4 million in 2011.
InvestmentExpand
BioCatch Team
Employee Info
| Employees (range) | 201-500 |
| Exact count | 435 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
BioCatch Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 101/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 514522895 |
| Crunchbase | biocatch |
| Phone | +972733725430 |
| Creator | Rebecca Mack |
| Creator email | rebeccamack26@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-02-06T00:00:00.000Z |
| Created | 2013-07-05T00:00:00.000Z |
| Claimed | Yes |
| Status detail | Acquired by Permira on May, 2024 |